Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Brigham and Women's Hospital
With
This is a randomized placebo-controlled 2-period crossover study. Each crossover period will consist of 14 days of QHS dosing of either AD036 or placebo, with a washout period of 7 days between each period. Polysomnography will be performed at screening (baseline) and on the last dosing day of each of the two crossover dosing period. The trial will enroll participants until a total of 24 responders are randomized into the crossover portion of the study.
Age
25–70
Sex
ALL
Healthy volunteers
Accepted
